|
Revenue
|
209.71B | 221.98B | 0.13B |
|
Cost of Revenue
|
22.00B | 30.54B | 0.03B |
|
Gross Profit
|
187.71B | 191.44B | 0.13B |
|
Research & Development
|
-743.10B | -706.97B | 0.13B |
|
Selling, General & Administrative
|
-170.59B | -181.08B | -25.64B |
|
Other Operating Expenses
|
913.70B | 888.05B | 25.51B |
|
Operating Expenses
|
0.00B | 0.00B | 0.00B |
|
Operating Income
|
187.71B | 191.44B | 0.13B |
|
Interest & Investment Income
|
| -0.00B | -0.01B |
|
EBIT
|
187.71B | 191.44B | 0.13B |
|
EBT
|
-887.17B | -932.86B | -0.05B |
|
Tax Provisions
|
4.25B | 7.15B | 0.00B |
|
Profit After Tax
|
-882.92B | -925.71B | -0.06B |
|
Income from Non-Controlling Interests
|
| -0.07B | -0.00B |
|
Income from Continuing Operations
|
-891.42B | -940.01B | -0.06B |
|
Consolidated Net Income
|
-891.42B | -940.01B | -0.06B |
|
Income towards Parent Company
|
-882.92B | -925.64B | -0.06B |
|
Net Income towards Common Stockholders
|
-882.92B | -925.64B | -0.06B |
|
EPS (Basic)
|
-0.00B | -0.00B | -0.00B |
|
EPS (Weighted Average and Diluted)
|
-0.00B | -0.00B | -0.00B |
|
Shares Outstanding (Weighted Average)
|
| 0.31B | 0.31B |
|
EBITDA
|
187.71B | 191.44B | 0.13B |